Gufic Biosciences | GUFICBIO | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2017
2018
2019
2020
2021
Net Income
Net Income
180
160
219
229
442
Cash flow Operating Act...
Cash flow Operating Activities
-44-4952457891
Investments in PPE
Investments in PPE
-35-81-131-401-142
Cash flow Investing Act...
Net cash used for Investment Activities
-33-88-130-424-85
Dividend Paid
Dividend Paid
44454
Cash flow Financing Act...
Net cash provided by Financing Activities
7114577-27-786
Cash at beginning of period
Cash at beginning of period
6229373743
Cash at end of period
Cash at end of period
5537374262
Free Cash Flow
Free Cash Flow
-79
-130
-79
56
749